Jose Miguel
Rivera Caravaca
Profesor Permanente Laboral
Liverpool Heart and Chest Hospital NHS Trust
Liverpool, Reino UnidoPublications in collaboration with researchers from Liverpool Heart and Chest Hospital NHS Trust (30)
2024
-
Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients
Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842
2023
-
Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
Diabetes, Obesity and Metabolism, Vol. 25, Núm. 2, pp. 602-610
-
Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea
FASEB Journal, Vol. 37, Núm. 6
-
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
Journal of General Internal Medicine, Vol. 38, Núm. 2, pp. 315-323
2022
-
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465
-
Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry
European Journal of Clinical Investigation, Vol. 52, Núm. 4
-
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 2, pp. 202-210
-
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence
British Journal of Clinical Pharmacology, Vol. 88, Núm. 1, pp. 282-289
-
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Clinical Research in Cardiology, Vol. 111, Núm. 9, pp. 1040-1047
-
Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
American Heart Journal
-
Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients
European Journal of Internal Medicine
-
Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
Journal of Personalized Medicine, Vol. 12, Núm. 3
-
Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
Journal of Thrombosis and Thrombolysis, Vol. 54, Núm. 1, pp. 1-6
-
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study
European Journal of Clinical Investigation
2021
-
Antithrombotic therapy in patients with peripheral artery disease: A focused review on oral anticoagulation
International Journal of Molecular Sciences, Vol. 22, Núm. 13
-
Cardiovascular risk factors, cardiovascular disease, and COVID-19: An umbrella review of systematic reviews
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 7, Núm. 4, pp. 330-339
-
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
Thrombosis Research, Vol. 205, pp. 1-7
-
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Cardiovascular Diabetology, Vol. 20, Núm. 1
-
Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: A review of potential implications
Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-16
-
Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real-world’
International Journal of Clinical Practice, Vol. 75, Núm. 4